We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+14.58%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$865M
AUM Growth
+$9.54M
(+1.1%)
Cap. Flow
-$78.4M
Cap. Flow
% of AUM
-9.07%
Top 10 Holdings %
Top 10 Hldgs %
8.56%
Holding
892
New
315
Increased
150
Reduced
128
Closed
299
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XP
XP
|
+$7.27M |
| 2 |
Constellation Brands
STZ
|
+$7.01M |
| 3 |
Eli Lilly
LLY
|
+$6.9M |
| 4 |
Automatic Data Processing
ADP
|
+$6.79M |
| 5 |
Nu Holdings
NU
|
+$6.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$11.9M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$11.9M |
| 3 |
Microsoft
MSFT
|
+$11.8M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$11.7M |
| 5 |
Las Vegas Sands
LVS
|
+$11.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.67% |
| 2 | Healthcare | 18.49% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Industrials | 10.31% |
| 5 | Financials | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Blue Owl Capital
OBDC
$5.61B
| $380K | 0.04% |
25,726
-44,813
| -64% | -$637K |
|
477
Duolingo
DUOL
$5.71B
| $379K | 0.04% |
+1,669
| New | +$325K |
|
478
EOG Resources
EOG
$71.4B
| $377K | 0.04% |
+3,120
| New | +$388K |
|
479
Bruker
BRKR
$7.8B
| $377K | 0.04% |
+5,135
| New | +$329K |
|
480
Chegg
CHGG
$98.4M
| $374K | 0.04% |
32,906
-127,827
| -80% | -$1.21M |
|
481
General Mills
GIS
$19.3B
| $373K | 0.04% |
+5,728
| New | +$370K |
|
482
Ameris Bancorp
ABCB
$5.92B
| $372K | 0.04% |
+7,020
| New | +$300K |
|
483
Jefferies Financial Group
JEF
$13B
| $372K | 0.04% |
9,209
-38,372
| -81% | -$1.36M |
|
484
Philip Morris
PM
$293B
| $372K | 0.04% |
+3,951
| New | +$364K |
|
485
Mitsubishi UFJ Financial
MUFG
$254B
| $369K | 0.04% |
+42,876
| New | +$362K |
|
486
Northrop Grumman
NOC
$80.7B
| $368K | 0.04% |
+786
| New | +$368K |
|
487
SLM Corp
SLM
$5.15B
| $366K | 0.04% |
19,156
-60,400
| -76% | -$912K |
|
488
Tractor Supply
TSCO
$17.9B
| $366K | 0.04% |
8,515
-70,355
| -89% | -$2.87M |
|
489
Guardant Health
GH
$21.1B
| $364K | 0.04% |
13,464
-72,345
| -84% | -$1.9M |
|
490
Maximus
MMS
$3.06B
| $358K | 0.04% |
+4,264
| New | +$340K |
|
491
Huntsman Corp
HUN
$1.78B
| $353K | 0.04% |
14,065
-6,635
| -32% | -$161K |
|
492
Teledyne Technologies
TDY
$31.9B
| $348K | 0.04% |
+780
| New | +$313K |
|
493
Insight Enterprises
NSIT
$4.51B
| $348K | 0.04% |
+1,963
| New | +$306K |
|
494
First Solar
FSLR
$26.2B
| $344K | 0.04% |
1,995
-27,613
| -93% | -$4.22M |
|
495
Cadence Design Systems
CDNS
$93.2B
| $342K | 0.04% |
+1,256
| New | +$324K |
|
496
Cognizant
CTSH
$25.6B
| $340K | 0.04% |
+4,507
| New | +$311K |
|
497
Sprouts Farmers Market
SFM
$8.13B
| $339K | 0.04% |
+7,056
| New | +$309K |
|
498
Brighthouse Financial
BHF
$3.57B
| $336K | 0.04% |
+6,347
| New | +$315K |
|
499
H&R Block
HRB
$5.82B
| $334K | 0.04% |
6,897
-54,609
| -89% | -$2.43M |
|
500
Liberty Broadband Class C
LBRDK
$5.32B
| $333K | 0.04% |
+4,129
| New | +$347K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q4 2023 Portfolio in Review
As of Q4 2023, Seven Eight Capital held 892 positions worth $865M, up 1.1% from $855M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.
Seven Eight Capital withdrew a net $78.4M in Q4 2023, closing 299 positions and reducing 128 holdings. Its most notable exit was Merck, an estimated $11.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Seven Eight Capital opened a new position in XP worth $8.3M.
- Seven Eight Capital's largest Q4 2023 buy was XP: 318,542 shares worth $8.3M.
- Seven Eight Capital added most to Constellation Brands in Q4 2023, an estimated $7.01M increase.
- Seven Eight Capital's biggest Q4 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $11.9M.
- Seven Eight Capital fully exited Merck in Q4 2023, selling an estimated $11.9M.
- Seven Eight Capital's ten largest holdings make up 8.6% of its $865M portfolio in Q4 2023.
- Seven Eight Capital opened 315 new positions and closed 299 in Q4 2023.
- Seven Eight Capital's portfolio value rose 1.1% quarter-over-quarter to $865M.
Based on Seven Eight Capital's 13F filing for Q4 2023, filed 13 Feb 2024.